Skip to content

Nanobiotix

US · NBTX #3096 by market cap Listed 2020
24.62 -0.61 -2.42%
Live - 5344 symbols - heartbeat 371s ago · 2026-10-08 05:24
Pre-market 23.72 -3.65%
After-hours 24.62 0.00%
Overnight 24.06 -2.27%
Market cap
1.25B
P/B
-33.54
EPS
-0.56
Reader sentiment Are you bullish or bearish on NBTX?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Guggenheim Maintains Nanobiotix(NBTX.US) With Buy Rating, Maintains Target Price $64
    Market Newswire · 2026/9/25
  • Rating change
    Guggenheim Maintains Nanobiotix(NBTX.US) With Buy Rating, Cuts Target Price to $8
    Market Newswire · 2025/4/5
  • Rating change
    TD Cowen Initiates Nanobiotix(NBTX.US) With Buy Rating
    Market Newswire · 2026/2/6
  • Guggenheim Initiates Nanobiotix(NBTX.US) With Buy Rating, Announces Target Price $64
    Market Newswire · 2026/9/15
  • Guggenheim Maintains Nanobiotix(NBTX.US) With Buy Rating, Raises Target Price to $36
    Market Newswire · 2026/4/2
  • Rating change
    Guggenheim Initiates Nanobiotix(NBTX.US) With Buy Rating, Announces Target Price $12
    Market Newswire · 2024/8/28
  • Earnings Call Summary | Nanobiotix(NBTX.US) Q4 2025 Earnings Conference
    Market Newswire · 2026/4/2
  • Rating change
    Leerink Partners Maintains Nanobiotix(NBTX.US) With Buy Rating, Raises Target Price to $14
    Market Newswire · 2025/9/19
  • Guggenheim Maintains Nanobiotix(NBTX.US) With Buy Rating, Maintains Target Price $36
    Market Newswire · 2026/5/5
  • Rating change
    Leerink Partners Maintains Nanobiotix(NBTX.US) With Buy Rating, Raises Target Price to $37
    Market Newswire · 2026/4/1
  • Rating change
    Leerink Partners Maintains Nanobiotix(NBTX.US) With Buy Rating, Announces Target Price $9
    Market Newswire · 2025/5/24
  • Rating change
    Guggenheim Maintains Nanobiotix(NBTX.US) With Buy Rating, Maintains Target Price $8
    Market Newswire · 2025/7/9
  • Rating change
    TD Cowen Maintains Nanobiotix(NBTX.US) With Buy Rating
    Market Newswire · 2026/4/2
  • Rating change
    Leerink Partners Maintains Nanobiotix(NBTX.US) With Buy Rating, Raises Target Price to $24
    Market Newswire · 2025/10/1
  • Rating change
    UBS Initiates Nanobiotix(NBTX.US) With Hold Rating, Announces Target Price $3.5
    Market Newswire · 2025/4/6

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 05:24:16 · For reference only, not investment advice and not tailored to your situation.